Page 130 - Feline Cardiology
P. 130

Chapter 11: Hypertrophic Cardiomyopathy  129


                                                                 not devoid of risk of adverse cardiac sequelae. Additional
                                                                 information in cats with focal basilar septal hypertrophy
                                                                 is needed, including genetic analysis, detailed assessment
                                           RV                    of other concurrent cardiac abnormalities such as dia-
                                                                 stolic  dysfunction,  SAM  of  the  mitral  valve,  clinical
                                                                 course,  and  pathologic  evaluation,  which  may  better
                                                Ao               characterize this subset of feline patients.
                              P        LV
                                                                   Left  ventricular  wall  thickness  obtained  by
                                                                 2-dimensional echocardiography is useful for obtaining
                                            LA                   the  diagnosis,  but  measurements  vary  according  to
                                                                 region of the left ventricle measured and the time within
                                                                 the cardiac cycle that the image frame was obtained for
                                                                 measurements.  There  is  high  inter-  and  intraobserver   Cardiomyopathies
              Figure  11.11.  Right	 parasternal	 long-axis	 view	 of	 concentric	  variability for measurements of septal and left ventricu-
              hypertrophy	of	the	basilar	interventricular	septum	in	a	cat	with	  lar  free  wall  end-  diastolic  thicknesses  in  awake  cats
              hypertrophic	cardiomyopathy.	Sometimes	there	is	asymmetrical	  (18%  and  20%,  respectively)  (Chetboul  et  al.  2004).
              or	segmental	hypertrophy	of	the	left	ventricle	in	cats	with	HCM.	  Therefore, serial quantification of left ventricular hyper-
              This	cat	has	severe	basilar	interventricular	septal	hypertrophy	(ar-  trophy  and  assessment  of  changes  in  left  ventricular
              row;	9	mm	thickness),	papillary	(P)	hypertrophy,	and	equivocal	to	  hypertrophy  following  pharmacologic  therapy  can  be
              mild	left	ventricular	free	wall	concentric	hypertrophy.	Sometimes	  challenging and highly dependent on the sites chosen for
              the	basilar	interventricular	septum	is	best	imaged	by	the	right	  wall measurement.
              parasternal	long-axis	left	ventricular	outflow	tract	view	as	shown	  Although  left  ventricular  concentric  hypertrophy  is
              here,	and	measurement	of	this	region	can	be	done	using	this	view.
                                                                 typically defined as a maximal end-diastolic wall thick-
                                                                 ness  of  6 mm  or  greater,  there  are  alternative  criteria
              septum  compared  to  the  short-axis  view  (see  Figure   used by some cardiologists. One proposed method is to
              11.11).                                            divide  the  interventricular  septum  into  two  regions
                 Focal basilar concentric hypertrophy of the interven-  (basilar to middle; middle to apical) measured in both
              tricular septum (i.e., “basal or septal bulge”) may be seen   long-axis and short-axis views, and the left ventricular
              in some cats with HCM, although there is debate in both   (posterior) free wall measured in both long- and short-
              human medicine and veterinary medicine over whether   axis views on 2D echocardiography (Paige et al. 2009).
              normal individuals may also develop this as a benign,   Presence of concentric hypertrophy is defined as an end-
              age-related variant of normal versus a forme fruste of   diastolic wall thickness of 6 mm or greater in more than
              HCM (i.e., an atypical or attenuated manifestation of   50% of a wall segment, not just the maximal thickness
              the  disease)  (Belenkie  et  al.  1988;  Spirito  et  al.  1986;   in one part of the wall (Paige et al. 2009). This method
              Krasnow  1997;  Hecht  et  al.  1992).  Unfortunately,  the   yields fewer positive diagnoses of HCM. Another pro-
              debate is largely based on conjecture and opinion and   posed criterion is to define increased end-diastolic left
              lacks substantial data regarding clinical, pathologic, and   ventricular wall or septal thickness as 5.5 mm or greater,
              genetic characterization. Some leading human cardiolo-  because most normal cats do not have wall thickness of
              gists specializing in familial HCM favor the hypothesis   5.5 mm or greater, which yields greater positive diagno-
              that  focal  septal  hypertrophy  is  a  less  severe  form  of   ses and higher prevalence rates of LV hypertrophy in the
              HCM  caused  by  less  malignant  cardiac  genetic  muta-  general  feline  population  (Wagner  et  al.  2010).  For
              tions, and result in a more benign course associated with   example, when using the criteria of 6 mm or greater wall
              lack of symptoms and long survival times (Spirito et al.   thickness measured by 2D, 34% of 92 clinically healthy
              1989; Shapiro and Zezulka 1883). However, the course   cats were diagnosed with left ventricular hypertrophy,
              of disease  may not  be  as  benign  in people as initially   compared to a lower prevalence rate of 23% of cats using
              thought, and this hypothesis was evaluated in a prospec-  a  more  stringent  criteria  of  >50%  of  a  wall  segment
              tive study following a subset of 29 human patients with   having 6 mm or greater thickness (Wagner et al. 2010).
              no symptoms and mild focal left ventricular hypertro-  Likewise, the lowest prevalence rate (12%) was obtained
              phy attributed to HCM. Although 76% (22/29) of these   using the criteria of 6 mm or greater wall thickness mea-
              patients never developed symptoms over an average of   sured by M-mode, likely because M-mode missed many
              8 years of follow-up, 4 (14%) people died suddenly and   cats  with  segmental  ventricular  hypertrophy  (Wagner
              3 (10%) had progression of symptoms, indicating that   et al. 2010). Using a lower value of 5.5 mm or greater
              despite a later onset of mild hypertrophy, patients are   for diagnosing left ventricular hypertrophy led to the
   125   126   127   128   129   130   131   132   133   134   135